Development of novel SUV39H2 inhibitors that exhibit growth suppressive effects in mouse xenograft models and regulate the phosphorylation of H2AX

Por Vougiouklakis, Theodore, Saloura, Vassiliki, Park, Jae-Hyun, Takamatsu, Naofumi, Miyamoto, Takashi, Nakamura, Yusuke, Matsuo, Yo
Publicado no Oncotarget (2018)

Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer

Por Chung, Suyoun, Suzuki, Hanae, Miyamoto, Takashi, Takamatsu, Naofumi, Tatsuguchi, Ayako, Ueda, Koji, Kijima, Kyoko, Nakamura, Yusuke, Matsuo, Yo
Publicado em 2012

Critical Role for TSLC1 Expression in the Growth and Organ Infiltration of Adult T-Cell Leukemia Cells In Vivo

Por Dewan, M. Zahidunnabi, Takamatsu, Naofumi, Hidaka, Tomonori, Hatakeyama, Kinta, Nakahata, Shingo, Fujisawa, Jun-ichi, Katano, Harutaka, Yamamoto, Naoki, Morishita, Kazuhiro
Publicado em 2008

Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor

Por Chung, Suyoun, Kijima, Kyoko, Kudo, Aiko, Fujisawa, Yoshiko, Harada, Yosuke, Taira, Akiko, Takamatsu, Naofumi, Miyamoto, Takashi, Matsuo, Yo, Nakamura, Yusuke
Publicado no Oncotarget (2016)

T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemia

Por Alachkar, Houda, Mutonga, Martin, Malnassy, Gregory, Park, Jae-Hyun, Fulton, Noreen, Woods, Alex, Meng, Liping, Kline, Justin, Raca, Gordana, Odenike, Olatoyosi, Takamatsu, Naofumi, Miyamoto, Takashi, Matsuo, Yo, Stock, Wendy, Nakamura, Yusuke
Publicado no Oncotarget (2015)